You are being forwarded to your requested URL of http://www.healthlawpolicymatters.com/2016/07/22/fda-adjustment-to-orphan-drug-review-may-indicate-increased-scrutiny-of-designations/?utm_source=mondaq&utm_medium=syndication&utm_content=sourceoriginal&utm_campaign=